Jay Shetty joins Prenetics (NASDAQ: PRE) as IM8 ambassador, shareholder
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
Prenetics Global Limited, parent of premium health brand IM8, announced a multi-year global partnership with author and podcast host Jay Shetty, who becomes IM8’s Global Ambassador and a shareholder in Prenetics. This expands IM8’s reach beyond sport into Shetty’s large wellness-focused audience.
The announcement comes as IM8 raises its full-year 2026 revenue guidance to $190 million to $210 million after reporting preliminary Q1 2026 IM8 revenue of $33.8 million, nearly six times higher year over year. IM8’s May 2026 monthly revenue is tracking at about $15.5 million, implying roughly $186 million in annualized recurring revenue.
Positive
- IM8 raises 2026 revenue guidance to $190 million–$210 million after reporting preliminary Q1 2026 IM8 revenue of $33.8 million, nearly six times year-over-year, and tracking about $186 million in annualized recurring revenue for May 2026.
Negative
- None.
Insights
IM8 shows explosive early growth and adds a major wellness voice as equity partner.
Prenetics reports preliminary IM8 Q1 2026 revenue of $33.8 million, described as nearly 6x year-over-year, and lifts full-year 2026 IM8 revenue guidance to $190 million to $210 million. IM8’s May 2026 monthly revenue of about $15.5 million implies roughly $186 million in annualized recurring revenue, signaling rapid scale-up for a 17‑month‑old brand.
The partnership makes Jay Shetty both Global Ambassador of IM8 and a shareholder in Prenetics, alongside existing equity-aligned partners like David Beckham and Giannis Antetokounmpo. His audience exceeds 70 million followers and 700 million monthly views, focused on wellness and mindfulness, which aligns directly with IM8’s positioning.
Future performance will depend on Prenetics sustaining IM8’s growth, effectively using Shetty and other partners in global marketing, and executing on its raised 2026 revenue guidance while managing the risks referenced in its SEC filings and forward‑looking statements disclaimer.
Key Figures
Full-year 2026 IM8 revenue guidance: $190 million–$210 million
Preliminary Q1 2026 IM8 revenue: $33.8 million
IM8 May 2026 monthly revenue: $15.5 million
+3 more
6 metrics
Full-year 2026 IM8 revenue guidance
$190 million–$210 million
Raised full-year 2026 guidance for IM8 business
Preliminary Q1 2026 IM8 revenue
$33.8 million
Nearly 6x year-over-year growth for IM8 in Q1 2026
IM8 May 2026 monthly revenue
$15.5 million
Tracking level that implies about $186 million annualized recurring revenue
IM8 annualized recurring revenue milestone
Over $100 million
Surpassed within 11 months of IM8 operations
Daily IM8 servings
150,000 servings per day
Daily Ultimate Essentials delivered to consumers in 43 countries
International revenue mix
Over 60% of revenue
Portion of IM8 revenue generated outside the United States
Key Terms
annualized recurring revenue, forward-looking statements, Scientific Advisory Board, NSF Certified for Sport
4 terms
annualized recurring revenue financial
"IM8’s May 2026 monthly revenue is tracking at approximately $15.5 million, implying roughly $186 million in annualized recurring revenue."
Annualized recurring revenue is the predictable income a business expects to earn over a year from ongoing customer subscriptions or contracts. It’s similar to estimating how much money you would make in a year if your current monthly income stayed the same. Investors use this figure to assess the stability and growth potential of a company's revenue stream.
forward-looking statements regulatory
"This press release contains forward-looking statements."
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Scientific Advisory Board technical
"will collaborate with IM8’s Scientific Advisory Board on consumer education in foundational nutrition, sleep, and longevity."
A scientific advisory board is a group of independent experts—often scientists, clinicians or technical specialists—who give a company guidance on its research, product development and regulatory strategy. For investors, their role is like an external quality check: credible experts can reduce technical risk, improve the chance of regulatory approval or successful products, and boost confidence that management’s science claims are realistic and well-directed.
NSF Certified for Sport technical
"Daily Ultimate Essentials is NSF Certified for Sport, non-GMO, vegan, and free from common allergens..."
NSF Certified for Sport is a third-party safety seal showing a supplement or sports product has been independently tested to be free of banned substances, contaminants and undeclared ingredients, and that it was made under quality controls. For investors, this label matters because it lowers the chance of regulatory action, athlete bans, or recalls and typically boosts consumer trust and sales—think of it as a safety inspection sticker that helps a product sell more reliably in a sensitive market.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2026
Commission File Number 001-41401
Prenetics Global Limited
Unit 703-706, K11 Atelier 728 King’s Road, Quarry Bay Hong Kong | |||||
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
On May 20, 2026, Prenetics Global Limited (the “Company”) issued a press release announcing a multi-year global partnership with Jay Shetty. A copy of the press release is furnished as Exhibit 99.1 to this report on Form 6-K.
EXHIBIT INDEX
| Exhibit No. | Description | |||||||
| 99.1 | Press Release - Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Prenetics Global Limited | ||||||||
| By: | /s/ Danny Sheng Wu Yeung | |||||||
| Name: | Danny Sheng Wu Yeung | |||||||
| Title: | Chief Executive Officer | |||||||
| Date: May 20, 2026 | ||||||||
Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
•Multi-year partnership lands as Prenetics’ IM8 raises full-year 2026 revenue guidance to $190 million to $210 million following nearly 6x year-over-year growth in Q1 2026
•Shetty is IM8’s first global ambassador from outside the world of sport
•Joins an equity-aligned roster of David Beckham, Giannis Antetokounmpo, Aryna Sabalenka, Ollie Bearman, and Inter Miami CF (with Lionel Messi)
NEW YORK, N.Y., May 20, 2026 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), the parent company of IM8, the premium health and longevity brand co-founded with David Beckham, today announced a multi-year global partnership with #1 New York Times bestselling author and award-winning podcast host of On Purpose, and purpose-driven entrepreneur, Jay Shetty. Shetty becomes Global Ambassador of IM8 and a shareholder in Prenetics, demonstrating his long-term conviction in the brand and the Company.
Shetty becomes IM8’s first global ambassador from outside the world of sport, extending the brand’s reach into the global wellness, mindfulness, and longevity audience he has spent more than a decade building. The partnership formalizes a relationship that began as a customer first: Shetty has used IM8
Daily Ultimate Essentials every morning for nearly a year, on the recommendation of his physician, Dr. Darshan Shah.
“I don’t partner with products — I partner with things I actually use,” said Jay. “IM8 has been part of my daily routine for almost a year. My doctor, Darshan Shah, introduced me to it and what kept me consistent is how I feel: more stable energy throughout the day, sharper focus when I’m recording and writing, and a morning routine that finally feels foundational instead of complicated. Becoming an owner in the business felt like the natural next step.”
Danny Yeung, Co-Founder and CEO of Prenetics and IM8, said: “Jay is our first global ambassador from outside sport, and that was deliberate. He found IM8 through his own doctor and has been a daily user for nearly a year — that’s the only kind of ambassador relationship we’re interested in. Jay reaches over 70 million followers across platforms who genuinely care about how they live, sleep, eat, and think. Bringing him in as a Prenetics shareholder — not just a face — is how we build a brand that lasts decades, not seasons.”
THE PARTNERSHIP
Under the multi-year agreement, Shetty will appear across IM8’s global marketing, content, and product initiatives, and will collaborate with IM8’s Scientific Advisory Board on consumer education in foundational nutrition, sleep, and longevity. He joins a roster of equity-aligned partners — each of whom holds equity in Prenetics — that includes co-founder David Beckham, two-time NBA MVP Giannis Antetokounmpo, World No. 1 tennis player Aryna Sabalenka, Formula 1 driver Ollie Bearman, and Inter Miami CF (with name, image, and likeness rights to a minimum of four players including Lionel Messi).
His combined direct following exceeds 70 million followers and 700 million monthly views across social media platforms, and his podcast On Purpose has over 1 billion listens to date. The partnership reflects IM8’s consistent approach: partners build alongside the founders and share in the long-term value they help create.
For Jay Shetty Partnership media files, please find it here: https://im8health.com/pages/press
DAILY ULTIMATE ESSENTIALS AND BUSINESS MOMENTUM
Shetty’s daily-used product, IM8 Daily Ultimate Essentials, is the brand’s flagship: a single daily scoop delivering 90 science-backed ingredients engineered to replace a cabinet of supplements. Since launching 17 months ago with one product and zero revenue, IM8 now delivers approximately 150,000 servings every day to consumers in 43 countries, with over 60% of revenue generated outside the United States.
On May 14, 2026, Prenetics reported preliminary Q1 2026 IM8 revenue of $33.8 million — nearly 6x year-over-year growth — and raised its full-year 2026 IM8 revenue guidance to $190 million to $210 million. IM8’s May 2026 monthly revenue is tracking at approximately $15.5 million, implying roughly $186 million in annualized recurring revenue.
ABOUT JAY SHETTY
Jay Shetty is a #1 New York Times bestselling author, and host of the On Purpose podcast, widely recognized as one of the world’s leading health and wellness podcasts — with over 1 billion listens to date and was most recently recognized by Spotify as a Top 10 Global Podcast of 2025. He was named to TIME’s 2025 list of the 100 most influential creators.
Across social media platforms, Shetty's direct global community exceeds 70 million followers and over 700 million monthly views — a deeply engaged audience focused on wellness, mindfulness, and personal growth. As a global bestselling author, award winning podcast host, and purpose-driven entrepreneur, he has built one of the largest communities in personal development worldwide and has partnered with some of the world’s most recognized brands.
ABOUT PRENETICS
Prenetics Global Limited (NASDAQ: PRE) is a leading health sciences company dedicated to advancing human health and longevity. The Company’s flagship consumer brand, IM8, co-founded with David Beckham and trusted by NBA superstar Giannis Antetokounmpo, World No. 1 tennis player Aryna Sabalenka, F1 phenom Ollie Bearman, and Inter Miami CF, is redefining the premium daily nutrition category through science-backed formulations and global brand partnerships. Since its launch, IM8 has become one of the fastest-growing brands in consumer health, surpassing $100 million in annualized recurring revenue within just 11 months of operations, and now ships to 43 countries worldwide.
ABOUT IM8
IM8 is a wholly owned subsidiary of Prenetics (NASDAQ: PRE) and is a premium direct-to-consumer health and longevity brand co-founded with David Beckham. Its flagship product, Daily Ultimate Essentials, is an all-in-one daily nutrition system delivering 90 science-backed ingredients in a single scoop, engineered to replace a cabinet of supplements. Daily Ultimate Essentials is NSF Certified for Sport, non-GMO, vegan, and free from common allergens, artificial flavors, colors, and sweeteners. IM8 is supported by a Scientific Advisory Board including experts affiliated with Cedars-Sinai, NASA, and Mayo Clinic. Learn more at www.im8health.com.
CONTACTS
Media — IM8: press@im8health.com
Investor Relations — Prenetics: ir@prenetics.com
FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s goals, targets, projections, outlooks, beliefs, expectations, strategy, plans, objectives of management for future operations of the Company, and growth opportunities are forward-looking statements. Our guidance reflects management’s current estimates and assumptions as of the date of this release, is subject to significant risks and uncertainties, and is not a guarantee of future performance. Actual results may differ materially. In some cases, forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to,” “guidance,” “outlook,” “forecast,” or other similar expressions. Forward-looking statements are based
upon estimates and forecasts and reflect the views, assumptions, expectations, and opinions of the Company, which involve inherent risks and uncertainties, and therefore they should not be relied upon as being necessarily indicative of future results. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to: the Company may not be able to maintain and enhance its IM8 business and brand if it suffers negative publicity or fails to maintain a strong base of engaged customers and content creators, or otherwise fails to meet customers’ expectations; the Company’s ability to further develop and grow its business, including new products and services; and its ability to identify and execute on M&A opportunities. In addition to the foregoing factors, you should also carefully consider the other risks and uncertainties described in the “Risk Factors” section of the Company’s most recent registration statement and the prospectus therein, and the other documents filed by the Company from time to time with the U.S. Securities and Exchange Commission. Unless otherwise specified, all information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law. Nothing in this press release constitutes an offer to sell, or the solicitation of an offer to buy, any securities of the Company.
FAQ
What did Prenetics (PRE) announce regarding Jay Shetty and IM8?
Prenetics announced a multi-year global partnership with Jay Shetty, making him Global Ambassador of IM8 and a shareholder in Prenetics. He will appear across IM8 marketing, content, and product initiatives, and support consumer education on foundational nutrition, sleep, and longevity.
How did IM8’s 2026 revenue guidance change in this Prenetics 6-K?
Prenetics raised full-year 2026 IM8 revenue guidance to $190 million to $210 million. The increase follows preliminary Q1 2026 IM8 revenue of $33.8 million, described as nearly six times higher year over year, reflecting rapid growth of the IM8 brand.
What current revenue metrics did Prenetics disclose for IM8?
Prenetics disclosed preliminary Q1 2026 IM8 revenue of $33.8 million and said IM8’s May 2026 monthly revenue is tracking at about $15.5 million. That monthly figure implies roughly $186 million in annualized recurring revenue for the IM8 business line.
How large is IM8’s customer and geographic reach according to Prenetics?
Prenetics stated IM8 now delivers about 150,000 servings of its Daily Ultimate Essentials product every day to consumers in 43 countries, with over 60% of revenue generated outside the United States, highlighting IM8’s early international footprint.
Who are the other equity-aligned partners mentioned alongside Jay Shetty?
Alongside Jay Shetty, Prenetics lists equity-aligned partners including co-founder David Beckham, NBA player Giannis Antetokounmpo, tennis player Aryna Sabalenka, Formula 1 driver Ollie Bearman, and Inter Miami CF with rights to several players including Lionel Messi.
How fast has IM8 grown since launch according to Prenetics?
Prenetics reports IM8 launched 17 months ago with one product and no revenue. Since then, IM8 has surpassed $100 million in annualized recurring revenue within just 11 months of operations and has continued to grow toward the updated 2026 revenue guidance range.